abstract |
The invention relates to macrocyclic compounds of formula Ia and compositions containing these compounds acting as kinase inhibitors, in particular as inhibitors of RIP2 and / or its mutants, for use in the diagnosis, prevention and / or treatment of diseases associated with RIP2 kinase. Moreover, the present invention provides methods for using these compounds, for example, as a medicine or diagnostic tool. |